These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8754882)

  • 1. [Study of immunobiological properties of specific immunomodulators of the adjuvant type in experimental tuberculosis].
    Gorelova LA; Zemskova ZS; Panasek IA; Nekrasov AV; Puchkova NG; Moroz AM; Romanova RIu
    Probl Tuberk; 1996; (3):46-7. PubMed ID: 8754882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
    Yamamoto K
    Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of mice against Mycobacterium tuberculosis infection by immunization with aqueous fraction of Triton X-100-soluble cell wall proteins.
    Jeon BY; Kim HJ; Kim SC; Jo EK; Park JK; Paik TH; Kim SJ; Cho SN
    Scand J Immunol; 2008 Jan; 67(1):18-23. PubMed ID: 18021187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
    Andersen CS; Dietrich J; Agger EM; Lycke NY; Lövgren K; Andersen P
    Infect Immun; 2007 Jan; 75(1):408-16. PubMed ID: 17074845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
    Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
    Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection.
    Palendira U; Spratt JM; Britton WJ; Triccas JA
    Vaccine; 2005 Feb; 23(14):1680-5. PubMed ID: 15705472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of immunomodulator leukinferon on the course of experimental tuberculosis].
    Gedymin LE; Erokhin VV; Lepekha LN; Nikolaeva GM; Kaminskaia GO; Kuznetsov VP; Beliaev DL; Babaiants AA
    Probl Tuberk; 2003; (1):45-52. PubMed ID: 12652986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases.
    Barlan I; Bahceciler NN; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):365-77, ix. PubMed ID: 16701150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of resistance to tuberculosis in mice with defined components of Mycobacteria and with some unrelated materials.
    Ribi E; Granger DL; Milner KC; Yamamoto K; Strain SM; Parker R; Smith RW; Brehmer W; Azuma I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):345-56. PubMed ID: 6805154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action mechanism of cell wall skeleton of BCG and Nocardia rubra as immunomodulator].
    Ogura T; Yoshimoto T; Sakatani M; Nishikawa H; Masuno T; Kawase I; Namba M; Hirao F; Yamamura Y; Itoh M
    Nihon Rinsho; 1981 Apr; 39(4):1852-60. PubMed ID: 7031297
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.
    Meyer TJ; Azuma I; Ribi EE
    Immunology; 1975 Feb; 28(2):219-29. PubMed ID: 804436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis.
    Feng CG; Palendira U; Demangel C; Spratt JM; Malin AS; Britton WJ
    Infect Immun; 2001 Jun; 69(6):4174-6. PubMed ID: 11349095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacteria and allergies.
    Rook GA; Hamelmann E; Brunet LR
    Immunobiology; 2007; 212(6):461-73. PubMed ID: 17544831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
    Sambandamurthy VK; Derrick SC; Hsu T; Chen B; Larsen MH; Jalapathy KV; Chen M; Kim J; Porcelli SA; Chan J; Morris SL; Jacobs WR
    Vaccine; 2006 Sep; 24(37-39):6309-20. PubMed ID: 16860907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antigen-binding lymphocytes of tuberculin specificity in M. bovis-infected rabbits in the dynamics of treatment for tuberculosis].
    Karal'nik BV; Denisova TG; Plazun AA; Duĭsenova RB
    Probl Tuberk Bolezn Legk; 2006; (5):48-53. PubMed ID: 16850925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.